First human trial begins for new schizophrenia pill
Disease control
Recruiting now
This is the first study in humans to test the safety and how the body processes an experimental oral medication called NTX-253, being developed for schizophrenia. It will involve healthy adults and adults with stable schizophrenia who temporarily stop their regular antipsychotic …
Phase: EARLY_PHASE1 • Sponsor: Neurosterix • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC